博济医药：关于公司获得药物临床试验批准通知书的公告

Core Viewpoint - Boji Pharmaceutical has received approval from the National Medical Products Administration for its clinical trial application of "FCZR" [2] Group 1 - The company announced the approval of its clinical trial for "FCZR" on the evening of September 3 [2] - The approval is a significant step for the company's research and development efforts in the pharmaceutical sector [2]